Plastic and Reconstructive Surgery, Global Open (Oct 2022)

Orbital Exenteration and Brachytherapy for the Treatment of Pediatric, Fusion-positive, Recurrent Rhabdomyosarcoma

  • Joseph Lopez, MD, MBA,
  • Nancy Qin, BA,
  • Robbie Woods, MD,
  • Marjorie Golden, MFA, CDT,
  • Harrison Spatz, DMD, MS,
  • Jatin Shah, MD,
  • Leonard H. Wexler, MD,
  • Joseph Randazzo, DDS,
  • Suzanne L. Wolden, MD,
  • David H. Abramson, MD

DOI
https://doi.org/10.1097/GOX.0000000000004581
Journal volume & issue
Vol. 10, no. 10
p. e4581

Abstract

Read online

SUMMARY. A 20-month-old boy presented with biopsy-proven recurrent alveolar rhabdomyosarcoma without metastasis. He was previously treated with multiagent chemotherapy and external beam irradiation showing a complete response. Upon relapse, he was treated with chemotherapy, orbital exenteration, and brachytherapy. Customized, intraoperative brachytherapy has potential to limit the sequelae associated with radiation adjuvant therapy.